5-chloro-7-nitro-1,3-benzoxazole-2-thiol, 95.0%, 2g

(2-(Benzyloxy)-5-methylphenyl)boronic acid, 95.0%, 250mg

(S)-2-(3-Bromophenyl)-4-(tert-butyl)-4,5-dihydrooxazole, 95.0%, 1g

ETHYL IMIDAZO[1,2-B]PYRIDAZINE-2-CARBOXYLATE, 95.0%, 5g

8-hydroxy-1,2-dihydroisoquinolin-1-one, 97%, 250mg

(4-Formyl-cyclohexyl)-carbamic acid tert-butyl ester, 95.0%, 1g

4-(2-Aminoethyl)morpholine>98.0%(GC)(T)500g

Sodium hydroxide solution, ROTIPURAN® min. 32%, pa, 1 l, plastic packaging.

2,4-Dimethyl-2,4-pentanediol>96.0%(GC)25mL

2,2'-[iminobis(ethane-2,1-diyl)]bis(1H-isoindole-1,3(2H)-dione), 95%, 25g

2-(Sec-butyl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one, 97%, 500g

2-methyl-1-[3-(trifluoromethyl)benzoyl]piperazine, 95.0%, 5g

5-(Bromoacetyl)-3-(3,4-dichlorophenyl)isoxazole, 95.0%, 5g